康美药业 (600518)
Kangmei Pharmaceutical Co., Ltd.
K-Line Chart
No K-line data available
Company NameKangmei Pharmaceutical Co., Ltd.
Listing Date2001-03-19
Issue Price12.57RMB
Registered Capital1382889.66910k RMB
Legal RepresentativeLai Zhijian
Registered AddressEast Side of Liusha Jieshen Road, Puning City, Guangdong Province
IndustryTraditional Chinese Medicine II
Main BusinessChinese herbal medicine decoction pieces, western medicines, health foods and foods, Chinese patent medicines, medical devices, etc.
Company ProfileKangmei Pharmaceutical Co., Ltd. (600518) was founded in 1997 and listed on the Shanghai Stock Exchange in 2001. It is a large-scale listed enterprise in the "Smart+" big health industry, being a pioneer in China to integrate the internet across the entire traditional Chinese medicine (TCM) industry chain, comprehensively building a "Big Health + Big Platform + Big Data + Big Service" system for precise TCM industry chain services. It is a National High-Tech Enterprise. Ranked among China's Top 500 Enterprises, Global 2000 Enterprises, and Guangdong's Top 100 Taxpayers, it is a constituent stock of the SSE 50 Index and was the first pharmaceutical company in China's capital market to surpass a market value of 100 billion yuan. Total assets grew from 177 million yuan in 1997 to 65.337 billion yuan in 2017, an increase of 368 times.
Stock Details
1. Key Indicators
- Total Shares(W): 1382889.67
- Circulating A-Shares(W): 1382235.22
- Earnings Per Share(RMB): 0.0010
- Net Assets Per Share(RMB): 0.5197
- Operating Revenue(W RMB): 395960.35
- Total Profit(W RMB): 3059.30
- **Net Profit Attributable to Parent(W RMB) **: 1308.23
- Net Profit Growth Rate(%): 160.84
- Weighted Return on Equity(%): 0.1800
- Operating Cash Flow Per Share(RMB): 0.0100
- Undistributed Profit Per Share(RMB): -1.8714
- Capital Reserve Per Share(RMB): 1.3359
2. Main Business
The main business covers:
- Chinese herbal medicine trade
- Production and sales of prepared slices of Chinese crude drugs, Chinese patent medicines, health foods, chemical drugs, and medical devices
- Modern pharmaceutical logistics systems
3. Company Basic Information
- Company Name: Kangmei Pharmaceutical Co., Ltd.
- Listing Date: 2001-03-19
- Industry: Pharmaceutical Manufacturing
- Address: Tike Road, Xiameilin, Futian District, Shenzhen City, Guangdong Province
- Website: http://www.kangmei.com.cn
- Company Profile: The company was established on June 18, 1997, initiated by Puning Kangmei Industrial Co., Ltd., Puning International Information Consulting Service, Puning Jindian Pawnshop, and natural persons Xu Yanjun and Xu Dongjin, with a registered capital of 52.8 million yuan. Among them: Puning Kangmei Industrial Co., Ltd. subscribed for 41.2 million shares, accounting for 78% of the total share capital, using its evaluated assets of 23.092 million yuan in Guangdong Kangmei Pharmaceutical Co., Ltd. and 18.108 million yuan in cash at a 1:1 ratio. The other four initiators each subscribed for 2.9 million shares with 2.9 million yuan in cash at the same ratio, each accounting for 5.5% of the total share capital. The company's 18 million A-shares were issued online at a fixed price on February 26, 2001.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Guangdong Shennongshi Enterprise Management Partnership (Limited Partnership) | Corporate Entity | 350941.38 | 25.39 |
| 2 | China Construction Bank Corporation Guangdong Provincial Branch | Bank | 51525.20 | 3.73 |
| 3 | Kangmei Pharmaceutical Co., Ltd. Bankruptcy Estate Disposal Special Account | Corporate Entity | 18239.22 | 1.32 |
| 4 | Shanghai Pudong Development Bank Co., Ltd. Shenzhen Branch | Bank | 10354.15 | 0.75 |
| 5 | Tianjin Kunpeng Rongchuang Enterprise Management Consulting Co., Ltd. | Corporate Entity | 9816.75 | 0.71 |
| 6 | Agricultural Bank of China Limited Shenzhen Branch | Bank | 9337.76 | 0.68 |
| 7 | Bosera Fund - ICBC - Bosera - ICBC - Flexible Allocation No. 5 Specific Multiple Client Asset Management Plan | Asset Management Plan | 7941.69 | 0.57 |
| 8 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 7828.69 | 0.57 |
| 9 | Zhongrong Life Insurance Co., Ltd. - Dividend Product | Insurance | 4680.64 | 0.34 |
| 10 |
5. Concept Sectors
- Private Hospitals
- Guangdong-Hong Kong-Macao Greater Bay Area
- Vitamins
- Intelligent Healthcare
- AI Healthcare
Remarks
- Data update date: 2025-10-30
- Data source: Public market information